Govt Job for M.Pharm, M.Sc at NII: Salary 35000 per month

The National Institute of Immunology, New Delhi, is a leading research Institute in India with a long-standing reputation for scientific excellence.

The institute is equipped with state-of-the-art infrastructure for pursuing research in immunology and allied sciences. The Institute also imparts vigorous long-term research training leading to a Ph.D degree.

Post : Senior Research Fellow (Project) (One Position only)

Name of the project & Duration of the Project : Geno type- pheno type relationship in rare genetic disorders: Physicochemical analysis of mutations in GNE myopathy and phenotypic modulation by small molecule effectors funded by DBT. Tenable till-29.11.2021

Educational Qualifications : M.Sc. (Bioinformatics/ Biophysics/ Biotechnology or any other stream of biological/ physical sciences) with NET or B.Tech. (Biotechnology / Bioinformatics / IT) with NET or M.Tech. (Bioinformatics / Biotechnology / Computational Sciences) or M.Pharm and at least 2 years of research experience.

Desirable Qualifications : Prediction and analysis of Protein structure and Protein-Protein interactions (PPI), Docking and MD simulations, inhibitor design, development of bioinformatics tools and software’s for structure based analysis of PPI.

OR Development of databases and software’s for genome analysis, installation/support of public domain software’s for structural bioinformatics in LINUX environment and system administration of computing / storage servers of Bioinformatics Canter, NII. The candidates must highlight their experience in programming and database development in their CV.

Emoluments : The selected candidates will draw consolidated emoluments as per DST OM dated 30.01.2019. Senior Research Fellow (Project): Rs. 35,000/- per month plus 24% HRA

General Terms & Conditions
1. The candidates selected for the above posts will be on contract for one year or duration of the project whichever is shorter, at a time.

2. No hostel/ housing facility will be provided.

3. Applicants may clearly mention the category they belong to i.e. SC/ST/OBC/PH and attach documentary proof of the same.

4. No TA/DA will be paid for attending the interview, if called for.

5. Apart from sending application in the prescribed format given below, candidates should send complete Curriculum Vitae along with the names of three referees. Curriculum Vitae should contain details of the experimental expertise.

6. Canvassing in any form will be a disqualification.

HOW TO APPLY

Interested candidates may apply directly, STRICTLY IN THE PRESCRIBED FORMAT GIVEN BELOW, through e-mail, to the Investigator of the project, clearly indicating the name of the project along with their complete C.V., e-mail id, fax numbers, telephone numbers.

Only Short listed candidates will be called for interview and they required to submit attested copies of all their certificates and a Demand Draft of Rs 100/- drawn on Canara Bank or Indian Bank payable at Delhi/New Delhi in favour of the Director, NII (SC/ST/PH and Women candidates are exempted subject to submission of documentary proof), at the time of interview.

Name of the Project Investigator :Dr. Debasisa Mohanty Staff Scientist-VII Email: mompcoe@nii.ac.in

Applicants must write “Application for GDMM Project” in subject of the e-mail.

LAST DATE OF RECEIPT OF APPLICATIONS : July 26, 2021
PS: DUE TO OUTBREAK OF COVID -19 PANDEMIC, THE INTERVIEWWILL BE HELD THROUGH ONLINE MODE ONLY

Related Posts

  • Pharma
  • July 22, 2025
  • 145 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

  • Pharma
  • July 16, 2025
  • 570 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug